GNIMA DIAW: Open Payments
NPI 1184472318 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 31 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $119 |
| Indivior Inc. | 2 | $101 |
| Alkermes, Inc. | 4 | $88 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, INGREZZA, SUBLOCADE, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, SPRAVATO, LYBALVI.
Industry payments across WV — which companies pay providers there.
